PMC9899977_01
(A-D) CT of the patient before surgery.
fonc-13-990028-g001.jpg
PMC9899977_03_fonc-13-990028-g001.jpg
f1
The plain CT scan and contrast-enhanced CT scan showed a nodular lesion in the left adrenal gland, measuring approximately 3.4 cm in the right-left diameter x 3.0 cm in anterior-posterior diameter, with heterogeneous enhancement ( Figure 1 ).
PMC9899977_02
(A-F) MRI of the patient before surgery.
fonc-13-990028-g002.jpg
PMC9899977_03_fonc-13-990028-g002.jpg
f2
MRI scan + enhancement showed a rounded, well-defined nodule in the left adrenal gland, measuring approximately 3.2 cm in the right-left diameter x 2.7 cm in anterior-posterior diameter x 3.3 cm maximal superior-inferior diameter, with Delayed and progressive enhancement ( Figure 2 ).
PMC9899977_03
(A-D) CT of the patient before surgery.
fonc-13-990028-g001.jpg
PMC9899977_03_fonc-13-990028-g001.jpg
f1
The plain CT scan and contrast-enhanced CT scan showed a nodular lesion in the left adrenal gland, measuring approximately 3.4 cm in the right-left diameter x 3.0 cm in anterior-posterior diameter, with heterogeneous enhancement ( Figure 1 ).
(A-F) MRI of the patient before surgery.
fonc-13-990028-g002.jpg
PMC9899977_03_fonc-13-990028-g002.jpg
f2
MRI scan + enhancement showed a rounded, well-defined nodule in the left adrenal gland, measuring approximately 3.2 cm in the right-left diameter x 2.7 cm in anterior-posterior diameter x 3.3 cm maximal superior-inferior diameter, with Delayed and progressive enhancement ( Figure 2 ).
(A-F) The graph of immunohistochemical staining.
fonc-13-990028-g003.jpg
PMC9899977_03_fonc-13-990028-g003.jpg
f3
Schwannoma (left adrenal gland). S100 (+) ( Figure 3A ), CD56(+) ( Figure 3B ), CKL(-) ( Figure 3C ), SOX-10(+) ( Figure 3D ),VIM (+) ( Figure 3E ), ki-67 (3%) ( Figure 3F ), SMA (-), CD34 (vascular +). No recurrence was observed during the 33 months of follow-up ( Supplementary Figure 3 ).
(A, B) A Diagram of the Pathology.
fonc-13-990028-g004.jpg
PMC9899977_03_fonc-13-990028-g004.jpg
f4
Schwannoma (left adrenal gland). S100 (+) ( Figure 3A ), CD56(+) ( Figure 3B ), CKL(-) ( Figure 3C ), SOX-10(+) ( Figure 3D ),VIM (+) ( Figure 3E ), ki-67 (3%) ( Figure 3F ), SMA (-), CD34 (vascular +).